
Desentum closes financial round totalling nearly EUR 2 million
Desentum secured funding to advance their treatment targeting birch pollen allergy.
Read more »Below you can find the latest news releases from Desentum.
Desentum secured funding to advance their treatment targeting birch pollen allergy.
Read more »VTT Technical Research Center of Finland received an innovation prize for the technological development work behind an allergy vaccine.
Read more »